AlphAIalphai — Financial news for AI agents
SEC EDGARJUN 31 min read$NATRNeutralLow

Norman Daniel C sold $200K of NATR

Norman Daniel C (EVP & President, Asia) sold 9,713 shares of NATURES SUNSHINE PRODUCTS INC (NATR) at $20.64 ($0.20M total) on 2026-06-01.

Norman Daniel CJune 3, 2026
AI analysis
Relevance
4/10
Novelty
3/10
Actionability
Low
Sentiment · $NATR
Neutral
Timing
Form 4 filed 2026-06-03 covering sale dated 2026-06-01
Market alignment
Neutral—insider selling can be interpreted both ways, but this disclosure alone typically doesn’t drive price.
Why this matters for $NATR

Insider selling disclosed via Form 4; no new fundamentals or guidance changes are provided in the filing.

Relevance context

SEC Form 4 shows NATR EVP & President, Asia Norman Daniel C sold $200,476 of shares in an open-market transaction.

Price-impact prediction

Likely limited near-term impact; treat as low-signal unless part of broader insider selling trend.

Background

The article reports an SEC Form 4 insider transaction for Natures Sunshine Products (NATR).

Why it matters

The disclosure may slightly affect sentiment, but it does not introduce new operational, financial, or regulatory information.

Market relevance

Traders may note the sale as a minor sentiment datapoint, but there is no clear catalyst to reprice fundamentals.

Market effects

Sector

No sector read-across; this is company-specific insider activity only.

Regional

None indicated.

Global

None indicated.

Alternative perspectives

Contrarian view

Insider sales can be driven by diversification/taxes rather than bearish fundamentals, especially when not tied to a 10b5-1 plan.

Overlooked factors

The filing doesn’t state rationale; without context on prior insider activity or total insider ownership, signal strength is weak.

Key entities

  • insider
    Norman Daniel C

    EVP & President, Asia at Natures Sunshine Products; sold 9,713 shares on 2026-06-01.

  • issuer
    Natures Sunshine Products Inc

    Issuer of NATR shares; insider sale disclosed via SEC Form 4.

Read at source← All news

Related articles

APR 9
$NATRMed

NATR Financials: Revenue Breakdown, Margins & Competitor Comparison

Nature's Sunshine Products Inc (NATR) generates most of its revenue from the General Health segment, contributing 41.3% or $47.38M of total sales, followed by Digestive and Cardiovascular segments. The company demonstrates strong profitability with a gross margin of 72.52%, an operating margin of 4.30%, and a net margin of 3.65%, alongside a 12.32% Return on Equity. NATR, with a market capitalization of $462.55M, outperforms competitors like NAGE in gross margin but trails USNA.

Intellectia AI4 min
MAR 10
$ULTAMed

Wall Street Lifts Targets on Five Below, Ulta Beauty and Nature's Sunshine Ahead of Key Earnings Reports

Wall Street analysts have raised price targets on Five Below (FIVE), Ulta Beauty (ULTA), and Nature's Sunshine Products (NATR) ahead of their upcoming earnings reports, signaling confidence in their business momentum and execution. Barclays increased Five Below's target to $211, Canaccord Genuity lifted Ulta Beauty's to $799, and Nature's Sunshine's target was raised to $29. The revisions reflect analysts' positioning before the results, with varying degrees of implied upside for each company based on their current stock prices.

24/7 Wall St.3 min
DEC 10
$NATRMed

Is Nature's Sunshine Products, Inc. (NASDAQ:NATR) Trading At A 32% Discount?

Nature's Sunshine Products, Inc. (NASDAQ:NATR) currently appears to be trading at a significant discount, with its share price of US$21.51 signalling it might be 32% undervalued compared to its estimated fair value of US$31.76. This valuation is based on a 2-stage Discounted Cash Flow (DCF) model and suggests that the company's future cash flows make it an attractive investment, especially given its peers are trading at a 77% premium on average. Investors are encouraged to consider the assumptions behind DCF models and explore other fundamental factors like management and potential risks.

Yahoo Finance Singapore4 min
AUG 1
$NATRHigh

Nature's Sunshine (NATR) Q2 EPS Up 400%

Nature's Sunshine Products ( NASDAQ:NATR ) , a direct seller of nutritional supplements and wellness products, reported second quarter 2025 earnings on July 31, 2025. GAAP revenue and earnings per share ( EPS ) exceeded Wall Street expectations.

Motley Fool3 min